Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iddo Magen

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Neuropeptides|November 12, 2013
Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP)Iddo Magen, Illana Gozes
Brain Research|April 15, 2014
Oligonucleotide-based therapy for neurodegenerative diseasesIddo Magen, Eran Hornstein
Current Medicinal Chemistry|February 19, 2014
Davunetide: Peptide therapeutic in neurological disordersIddo Magen, Illana Gozes
Journal of Parkinson'S Disease|August 14, 2013
Mouse models of cognitive deficits due to alpha-synuclein pathologyIddo Magen, Marie-Françoise Chesselet
Progress in Brain Research|October 5, 2010
Genetic mouse models of Parkinson's disease The state of the artIddo Magen, Marie-Françoise Chesselet
Current Pharmaceutical Design|September 11, 2008
Endocannabinoids in liver disease and hepatic encephalopathyIddo Magen, Yosefa Avraham, Elliot Berry, et al.
Journal of Hepatology|July 15, 2009
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligationIddo Magen, Yosefa Avraham, Zvi Ackerman, et al.
The Journal of Biological Chemistry|October 6, 2005
Nutritional status, cognition, and survival: a new role for leptin and AMP kinaseYossi Dagon, Yosefa Avraham, Iddo Magen, et al.
Journal of Parkinson'S Disease|January 16, 2015
Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's DiseaseIddo Magen, Eileen Ruth Torres, Diana Dinh, et al.
Physiology & Behavior|February 19, 2022
Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in MiceYosefa Avraham, Bob Van Heukelom, Olga Zolotarev, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Neuropeptides|November 12, 2013
Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP)Iddo Magen, Illana Gozes
Brain Research|April 15, 2014
Oligonucleotide-based therapy for neurodegenerative diseasesIddo Magen, Eran Hornstein
Current Medicinal Chemistry|February 19, 2014
Davunetide: Peptide therapeutic in neurological disordersIddo Magen, Illana Gozes
Journal of Parkinson'S Disease|August 14, 2013
Mouse models of cognitive deficits due to alpha-synuclein pathologyIddo Magen, Marie-Françoise Chesselet
Progress in Brain Research|October 5, 2010
Genetic mouse models of Parkinson's disease The state of the artIddo Magen, Marie-Françoise Chesselet
Current Pharmaceutical Design|September 11, 2008
Endocannabinoids in liver disease and hepatic encephalopathyIddo Magen, Yosefa Avraham, Elliot Berry, et al.
Journal of Hepatology|July 15, 2009
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligationIddo Magen, Yosefa Avraham, Zvi Ackerman, et al.
The Journal of Biological Chemistry|October 6, 2005
Nutritional status, cognition, and survival: a new role for leptin and AMP kinaseYossi Dagon, Yosefa Avraham, Iddo Magen, et al.
Journal of Parkinson'S Disease|January 16, 2015
Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's DiseaseIddo Magen, Eileen Ruth Torres, Diana Dinh, et al.
Physiology & Behavior|February 19, 2022
Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in MiceYosefa Avraham, Bob Van Heukelom, Olga Zolotarev, et al.
Pageof 4